TipRanks
Revvity (GB:0KHE)
LSE:0KHE
UK Market

Revvity (0KHE) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0KHE Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
4 Buy
10 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Revvity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0KHE Stock 12 Month Forecast

Average Price Target

$141.75
▲(10.52% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $141.75 with a high forecast of $175.00 and a low forecast of $110.00. The average price target represents a 10.52% change from the last price of $128.26.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"85":"$85","176":"$176","107.75":"$107.8","130.5":"$130.5","153.25":"$153.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$175.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":141.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$141.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$110.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[85,107.75,130.5,153.25,176],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150.592,152.46953846153846,154.34707692307694,156.2246153846154,158.10215384615387,159.97969230769232,161.85723076923077,163.73476923076925,165.6123076923077,167.48984615384614,169.36738461538462,171.24492307692307,173.12246153846155,{"y":175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150.592,149.91184615384617,149.23169230769233,148.55153846153848,147.8713846153846,147.19123076923077,146.51107692307693,145.83092307692309,145.15076923076924,144.4706153846154,143.79046153846153,143.11030769230769,142.43015384615384,{"y":141.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150.592,147.46953846153846,144.34707692307694,141.2246153846154,138.10215384615387,134.97969230769232,131.85723076923077,128.73476923076925,125.6123076923077,122.48984615384616,119.36738461538462,116.24492307692307,113.12246153846155,{"y":110,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":89.78,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.771,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.654,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.911,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.831,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.325,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.607,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.551,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.814,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.727,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.919,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.663,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.592,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$175.00Average Price Target$141.75Lowest Price Target$110.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on GB:0KHE
Bernstein
Bernstein
$120
Hold
-6.44%
Downside
Assigned
10/19/26
Revvity (RVTY) Gets a Hold from Bernstein
J.P. Morgan Analyst forecast on GB:0KHE
J.P. Morgan
J.P. Morgan
$110→$155
Hold
20.85%
Upside
Reiterated
10/16/26
J.P. Morgan Sticks to Their Hold Rating for Revvity (RVTY)
TD Cowen
$130→$175
Buy
36.44%
Upside
Reiterated
10/13/26
Revvity price target raised to $175 from $130 at TD CowenRevvity price target raised to $175 from $130 at TD Cowen
Bank of America Securities Analyst forecast on GB:0KHE
Bank of America Securities
Bank of America Securities
$125→$165
Hold
28.64%
Upside
Reiterated
10/09/26
Revvity price target raised to $165 from $125 at BofARevvity price target raised to $165 from $125 at BofA
Barclays Analyst forecast on GB:0KHE
Barclays
Barclays
$115→$160
Hold
24.75%
Upside
Reiterated
10/07/26
Revvity (RVTY) Receives a Hold from Barclays
William Blair Analyst forecast on GB:0KHE
William Blair
William Blair
―
Buy
―
Initiated
10/05/26
Revvity initiated with an Outperform at William BlairRevvity initiated with an Outperform at William Blair
Goldman Sachs Analyst forecast on GB:0KHE
Goldman Sachs
Goldman Sachs
$100→$140
Hold
9.15%
Upside
Reiterated
09/20/26
Goldman Sachs Remains a Hold on Revvity (RVTY)
CFRA Analyst forecast on GB:0KHE
Unknown Analyst
CFRA
Not Ranked
CFRA
―
Hold
―
Downgraded
09/18/26
CFRA downgrades Revvity (RVTY) to a Hold
UBS Analyst forecast on GB:0KHE
Unknown Analyst
UBS
Not Ranked
UBS
$120→$140
Hold
9.15%
Upside
Initiated
09/08/26
Revvity (RVTY) Receives a New Rating from UBS
KeyBanc
$125→$165
Buy
28.64%
Upside
Reiterated
09/04/26
KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)
RBC Capital Analyst forecast on GB:0KHE
RBC Capital
RBC Capital
$135
Hold
5.25%
Upside
Initiated
09/01/26
Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital
Stifel Nicolaus Analyst forecast on GB:0KHE
Stifel Nicolaus
Stifel Nicolaus
$100→$110
Hold
-14.24%
Downside
Assigned
08/05/26
Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel
Evercore ISI Analyst forecast on GB:0KHE
Evercore ISI
Evercore ISI
$125→$126
Buy
-1.76%
Downside
Reiterated
08/05/26
Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI
Wells Fargo Analyst forecast on GB:0KHE
Wells Fargo
Wells Fargo
$110
Hold
-14.24%
Downside
Reiterated
08/05/26
Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)
Leerink Partners Analyst forecast on GB:0KHE
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on GB:0KHE
Bernstein
Bernstein
$120
Hold
-6.44%
Downside
Assigned
10/19/26
Revvity (RVTY) Gets a Hold from Bernstein
J.P. Morgan Analyst forecast on GB:0KHE
J.P. Morgan
J.P. Morgan
$110→$155
Hold
20.85%
Upside
Reiterated
10/16/26
J.P. Morgan Sticks to Their Hold Rating for Revvity (RVTY)
TD Cowen
$130→$175
Buy
36.44%
Upside
Reiterated
10/13/26
Revvity price target raised to $175 from $130 at TD CowenRevvity price target raised to $175 from $130 at TD Cowen
Bank of America Securities Analyst forecast on GB:0KHE
Bank of America Securities
Bank of America Securities
$125→$165
Hold
28.64%
Upside
Reiterated
10/09/26
Revvity price target raised to $165 from $125 at BofARevvity price target raised to $165 from $125 at BofA
Barclays Analyst forecast on GB:0KHE
Barclays
Barclays
$115→$160
Hold
24.75%
Upside
Reiterated
10/07/26
Revvity (RVTY) Receives a Hold from Barclays
William Blair Analyst forecast on GB:0KHE
William Blair
William Blair
―
Buy
―
Initiated
10/05/26
Revvity initiated with an Outperform at William BlairRevvity initiated with an Outperform at William Blair
Goldman Sachs Analyst forecast on GB:0KHE
Goldman Sachs
Goldman Sachs
$100→$140
Hold
9.15%
Upside
Reiterated
09/20/26
Goldman Sachs Remains a Hold on Revvity (RVTY)
CFRA Analyst forecast on GB:0KHE
Unknown Analyst
CFRA
Not Ranked
CFRA
―
Hold
―
Downgraded
09/18/26
CFRA downgrades Revvity (RVTY) to a Hold
UBS Analyst forecast on GB:0KHE
Unknown Analyst
UBS
Not Ranked
UBS
$120→$140
Hold
9.15%
Upside
Initiated
09/08/26
Revvity (RVTY) Receives a New Rating from UBS
KeyBanc
$125→$165
Buy
28.64%
Upside
Reiterated
09/04/26
KeyBanc Sticks to Their Buy Rating for Revvity (RVTY)
RBC Capital Analyst forecast on GB:0KHE
RBC Capital
RBC Capital
$135
Hold
5.25%
Upside
Initiated
09/01/26
Revvity initiated with a Sector Perform at RBC CapitalRevvity initiated with a Sector Perform at RBC Capital
Stifel Nicolaus Analyst forecast on GB:0KHE
Stifel Nicolaus
Stifel Nicolaus
$100→$110
Hold
-14.24%
Downside
Assigned
08/05/26
Revvity price target raised to $110 from $100 at StifelRevvity price target raised to $110 from $100 at Stifel
Evercore ISI Analyst forecast on GB:0KHE
Evercore ISI
Evercore ISI
$125→$126
Buy
-1.76%
Downside
Reiterated
08/05/26
Revvity price target raised to $126 from $125 at Evercore ISIRevvity price target raised to $126 from $125 at Evercore ISI
Wells Fargo Analyst forecast on GB:0KHE
Wells Fargo
Wells Fargo
$110
Hold
-14.24%
Downside
Reiterated
08/05/26
Wells Fargo Sticks to Its Hold Rating for Revvity (RVTY)
Leerink Partners Analyst forecast on GB:0KHE
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
07/17/26
Revvity (RVTY) Receives a Buy from Leerink Partners
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
ESTAEstablishment Labs Holdings
IRTCIrhythm Technologies
ZYMEZymeworks
ARDXArdelyx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revvity

3 Months
Success Rate
24/37 ratings generated profit
65%
Average Return
+3.05%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 64.86% of your transactions generating a profit, with an average return of +3.05% per trade.
1 Year
Success Rate
12/17 ratings generated profit
71%
Average Return
+23.62%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +23.62% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
11/11 ratings generated profit
100%
Average Return
+46.21%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +46.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0KHE Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
4
6
6
6
5
Hold
11
10
8
12
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
16
14
18
21
In the current month, 0KHE has received 5 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. 0KHE average Analyst price target in the past 3 months is 141.75.
Each month's total comprises the sum of three months' worth of ratings.

0KHE Financial Forecast

0KHE Earnings Forecast

Next quarter’s earnings estimate for 0KHE is $1.30 with a range of $1.28 to $1.33. The previous quarter’s EPS was $1.41. 0KHE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0KHE has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0KHE is $1.30 with a range of $1.28 to $1.33. The previous quarter’s EPS was $1.41. 0KHE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0KHE has Performed in-line its overall industry.

0KHE Sales Forecast

Next quarter’s sales forecast for 0KHE is $694.73M with a range of $690.60M to $703.00M. The previous quarter’s sales results were $729.69M. 0KHE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0KHE has Performed in-line its overall industry.
Next quarter’s sales forecast for 0KHE is $694.73M with a range of $690.60M to $703.00M. The previous quarter’s sales results were $729.69M. 0KHE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0KHE has Performed in-line its overall industry.

0KHE Stock Forecast FAQ

What is GB:0KHE’s average 12-month price target, according to analysts?
Based on analyst ratings, Revvity’s 12-month average price target is 141.75.
    What is GB:0KHE’s upside potential, based on the analysts’ average price target?
    Revvity has 10.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Revvity a Buy, Sell or Hold?
          Revvity has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 10 hold ratings and 0 sell ratings.
            What is Revvity’s share price target?
            The average share price target for Revvity is 141.75. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $175.00 ,and the lowest forecast is $110.00. The average share price target represents 10.52% Increase from the current price of $128.26.
              What do analysts say about Revvity?
              Revvity’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of Revvity?
                To buy shares of GB:0KHE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.